Trials / Completed
CompletedNCT02933905
Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (actual)
- Sponsor
- Fundació Institut Germans Trias i Pujol · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Influence of the vitreomacular interface on the progression of diabetic macular edema after treatment with intravitreal injection of vascular endothelial growth factor inhibitors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravitreal Ranibizumab injection |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-01-01
- Completion
- 2016-06-01
- First posted
- 2016-10-14
- Last updated
- 2016-10-18
Source: ClinicalTrials.gov record NCT02933905. Inclusion in this directory is not an endorsement.